In this webinar, Citeline's clinical and patient recruitment experts continue the conversation started in the BBC StoryWorks Rewriting Cancer series — moving from the human reality of what’s at stake to the practical strategies changing how sponsors approach patient recruitment today.
What if the patient who needed your trial most never heard about it?
It happens more often than it should. Thousands of clinical trials are open at any given moment — yet eligible patients go unidentified, sites miss qualified candidates, and enrollment timelines slip. The infrastructure to reliably connect the right patient to the right trial, at the right time, simply isn't there for most sponsors.
In this webinar, Citeline's clinical and patient recruitment experts continue the conversation started in the BBC StoryWorks Rewriting Cancer series — moving from the human reality of what’s at stake to the practical strategies changing how sponsors approach patient recruitment today.
Madeline Naylor, Citeline's Chief Clinician for Real-World Data, opens with a story that shaped her entire career. When her father was diagnosed with esophageal cancer, the option of a clinical trial was never raised. Not because one didn't exist — but because no one surfaced it. That experience is the reason she does this work. And it is the reason every match matters.
Joined by Suzanne Caruzo, Citeline expert in patient recruitment strategy, Madeline will walk through what it takes to close the gap between eligible patients and enrolled patients — combining AI, real-world data (RWD), and end-to-end clinical expertise to make sure no patient falls through the cracks.
This is a practical, expert-led session built for sponsors working on complex trials — with real examples, real data, and a clear path forward.
What You Will Get from This Session
A look at why enrollment keeps falling short — the structural, clinical, and operational barriers that prevent eligible patients from reaching the trials that could help them
A data-driven approach to smarter matching — how AI and RWD, including linked EMR records, claims, lab data, and clinician-reviewed algorithms, can surface protocol-matched patients earlier and more reliably than traditional methods
Strategies you can apply to your trial — a practical overview of how patient identification, feasibility, and patient journey insights work together across complex oncology and rare disease protocols
Proof it works — real-world examples showing how this approach has helped sponsors overcome recruitment roadblocks, accelerate enrollment timelines, and find the right sites in places traditional feasibility would never look
A clear next step — whether you are in early planning, mid-recruitment, or rethinking your strategy entirely, you’ll leave with concrete actions and an understanding of how Citeline's end-to-end recruitment capabilities can support your specific situation
ヘルスサイエンス博士号（Doctor of Health Science）および医科学修士号（Master of Medical Science）を取得しており、臨床研究コーディネーター認定（Clinical Research Coordinator Certification）をAssociation of Clinical Research Professionals（ACRP）より取得しています。
Suzanne Caruso
President, Norstella
Suzanne Caruso is a senior business executive and clinical trial study start-up expert with over 15 years of experience in the pharmaceutical industry. As the General Manager of Clinical & Regulatory at Norstella, she leverages her expertise in artificial intelligence (AI), data analytics, and innovative trial operational models to drive efficiency for large pharma, biotech, and CRO companies. Suzanne has held roles at Veeva Systems, WCG, GSK, and Novartis and has served as a subject matter expert and adviser to over 50 organizations.
